Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) Announces Executive and Board Changes
Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) announced changes to its leadership team and board of directors.
Executive Officer was appointed. The position includes: Class III, Governance Committee, Nominating and Corporate Governance Committee. The change is effective as of June 8, 2022.
Executive Changes Details:
Personnel Involved: Executive Officer, Director On
Actions: Appointed, Elected, Departed
Committee Assignments: Governance Committee, Nominating and Corporate Governance Committee
Board Classification: Class III
👥 Executive & Board Changes:
Personnel Involved: Executive Officer, Director On
Actions: Appointed, Elected, Departed
Committee Assignments: Governance Committee, Nominating and Corporate Governance Committee
Effective Dates: June 8, 2022, June 10, 2022, March 3, 2022, June 30, 2022, June 9, 2022, April 12, 2019
💼 Business Developments:
Partnership
Acquisition: Not available
Licensing: Not available
Regulatory Approval
Executive Changes
Structured Data:
Company Name: Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX))
📋 CORTEXYME, INC. (CRTX) - Executive Changes
Filing Date: 2022-06-10
Accepted: 2022-06-10 17:01:03
Event Type: Executive Changes
Event Details:
👥 Executive & Board Changes:
💼 Business Developments:
Structured Data: